James Stirling Ro
Dados Biográficos
| ID | 354037 |
|---|---|
| NOME | James Stirling Ro |
| PRENOMES | James Stirling |
| SOBRENOME | Ro |
| ASSINATURA | RO J S |
| AFILIAÇÕES | Yale University |
| ORCID | 0000-0002-9218-3320 |
| VERIFICADO | Sim |
| TOTAL DE OBRAS | 31 |
| TOTAL DE CITAÇÕES | 10 |
| TOTAL COMO AUTOR | 31 |
| TOTAL COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 1953 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2025 |
| ÍNDICE H | 2 |
Early Recalls and Clinical Validation Gaps in Artificial Intelligence–Enabled Medical Devices
This cross-sectional study examines whether lack of clinical validation and publicly traded manufacturer status were associated with recalls of artificial intelligence–enabled medical devices that had been cleared by the US Food and Drug Administration
Public Health Implications of Legal Challenges to the FDA’s Regulation of Laboratory-Developed Tests
The case of LDTs illustrates the challenges the FDA faces when adapting regulatory frameworks in response to emerging health technologies. The outcomes of recent reforms and litigation carry substantial public health implications for both diagnostic technologies and the FDA's broader regulatory remit
Online Advertising of Compounded Glucagon-Like Peptide-1 Receptor Agonists
This cross-sectional study evaluates the quality and accuracy of information presented on websites that sell compounded glucagon-like peptide-1 receptor agonists
Hospital Acquisition Costs for Breakthrough-Designated Devices Awarded Supplemental Medicare Reimbursement
This cross-sectional study compares manufacturer-reported and actual hospital acquisition costs for breakthrough-designated devices awarded supplemental Medicare reimbursement
Biomedical retractions due to misconduct in Europe
The aim was to describe biomedical retractions and analyse those retracted in 2000–2021 due to research misconduct among authors affiliated with European institutions. A cross-sectional study was conducted, using Retraction Watch database, Journal Citation Reports and PubMed as data sources. Biomedical original papers, reviews, case reports and letters with at least one author affiliated with an European institution retracted between 01/01/2000 a…
Research misconduct as a challenge for academic institutions and scientific journals
Research misconduct refers to a set of unethical practices in research and publication and is the main reason for retraction of articles published in the academic literature. Research misconduct has negative consequences and has generated public scepticism about research, which has led to increasing distrust in science. In this context, a joint effort by the scientific community, academic institutions, scientific journals and research funders is …
On a Writing & Walking Field Trip with Seven High School Boys Exploring Langston Hughes Sites in Washington, D.C
The city teaches us todaywith brick row houses andfront stoops, bicyclists,the squeal of car brakes.Hurried drivers watch uswaiting on a sidewalk,writing on his front steps.Bikes hiss by, their spokessparkle against a grey sky.My students gazeat Langston’s windows,wondering what poem beganhere, what poem ended here,what poem was tossed away.One moment, they are a riotof laughter, shining withsilly, colliding with each other.The next, they searcht…
Extending the US Food and Drug Administration’s Postmarket Authorities
Under current FDA approaches to drug approval, patients, clinicians, and payers may be left with little confidence about a drug's benefit not only when it first enters the market but also for an extended period thereafter. If policy makers continue to favor earlier market access over evidentiary certainty, flexible approvals must be matched by more expansive use of postmarket safeguards, an approach possible within the FDA's existing legal author…
Spending by the Centers for Medicare & Medicaid Services Before and After Confirmation of Benefit for Drugs Granted US Food and Drug Administration Accelerated Approval, 2012 to 2017
The findings of this cross-sectional study indicate that most of the drugs granted FDA accelerated approval for original indications from 2012 to 2017 lacked confirmatory trials evaluating clinical outcomes to support conversion to standard approval. Automatic coverage mandates produced substantial CMS spending for drugs with unproven clinical benefits
Rural Perceptions of Acute Care at Home
PURPOSE: Hospital-level care at home in urban areas delivers low-cost, high-quality care. Few have attempted to deliver home hospital care in a rural environment, where traditional hospitals are often less equipped to deliver high-quality care. Little is known about rural clinicians' and patients' perceptions regarding rural home hospital care and how the urban model might be adapted to fit rural circumstances. METHODS: We conducted semistructure…
Identification of Hospitals That Care for a High Proportion of Patients With Social Risk Factors
In this cross-sectional study, there were inconsistencies in the identification of hospitals caring for disadvantaged populations using different definitions of social risk factors. Without consensus on how to define disadvantaged hospitals, policies to support such hospitals may be applied inconsistently
Reporting of substance use treatment quality in United States adult drug courts
Defining Multiple Chronic Conditions for Quality Measurement
BACKGROUND/OBJECTIVE: Patients with multiple chronic conditions (MCCs) are a critical but undefined group for quality measurement. We present a generally applicable systematic approach to defining an MCC cohort of Medicare fee-for-service beneficiaries that we developed for a national quality measure, risk-standardized rates of unplanned admissions for Accountable Care Organizations. RESEARCH DESIGN: To define the MCC cohort we: (1) identified po…
Statewide Inferior Vena Cava Filter Placement, Complications, and Retrievals
BACKGROUND: Public awareness of inferior vena cava (IVC) filter-related controversies has been elevated by the Food and Drug Administration (FDA) safety communication in 2010. OBJECTIVES: To examine population level trends in IVC filter utilization, complications, retrieval rates, and subsequent pulmonary embolism (PE) risk. DESIGN: A retrospective cohort study. SUBJECTS: Patients receiving IVC filters during 2005-2014 in New York State. MEASURES…
For transparency and accountability more is better
Factors Associated with Refugee Acute Healthcare Utilization in Southern Connecticut
Hospital Characteristics Associated With Risk-standardized Readmission Rates
BACKGROUND: Safety-net and teaching hospitals are somewhat more likely to be penalized for excess readmissions, but the association of other hospital characteristics with readmission rates is uncertain and may have relevance for hospital-centered interventions. OBJECTIVE: To examine the independent association of 8 hospital characteristics with hospital-wide 30-day risk-standardized readmission rate (RSRR). DESIGN: This is a retrospective cross-s…
Quality of Care in the United States Territories, 1999–2012
BACKGROUND: Millions of Americans live in the US territories, but health outcomes and payments among Medicare beneficiaries in these territories are not well characterized. METHODS: Among Fee-for-Service Medicare beneficiaries aged 65 years and older hospitalized between 1999 and 2012 for acute myocardial infarction (AMI), heart failure (HF), and pneumonia, we compared hospitalization rates, patient outcomes, and inpatient payments in the territo…
Risk-standardized Acute Admission Rates Among Patients With Diabetes and Heart Failure as a Measure of Quality of Accountable Care Organizations
BACKGROUND: Population-based measures of admissions among patients with chronic conditions are important quality indicators of Accountable Care Organizations (ACOs), yet there are challenges in developing measures that enable fair comparisons among providers. METHODS: On the basis of consensus standards for outcome measure development and with expert and stakeholder input on methods decisions, we developed and tested 2 models of risk-standardized…
Hospital Use of Observation Stays
BACKGROUND: The Centers for Medicare and Medicaid Services publicly reports hospital risk-standardized readmission rates (RSRRs) as a measure of quality and performance; mischaracterizations may occur because observation stays are not captured by current measures. OBJECTIVES: To describe variation in hospital use of observation stays, the relationship between hospitals observation stay use and RSRRs. MATERIALS AND METHODS: Cross-sectional analysi…
US Federal Government Efforts to Improve Clinical Trial Transparency with Expanded Trial Registries and Open Data Sharing
In 2014, the Department of Health and Human Services and the National Institutes of Health published proposals to expand clinical trial registration requirements and to promote sharing of clinical research data, but these and other efforts at improving data transparency and access need to be supported by changes in the academic reward structure and significant funding
Variation in US Hospital Emergency Department Admission Rates by Clinical Condition
BACKGROUND: Variation in hospitalization rates have been described for decades, yet little is known about variation in emergency department (ED) admission rates across clinical conditions. We sought to describe variation in ED risk-standardized admission rates (RSAR) and the consistency between condition-specific ED admission rates within hospitals. METHODS: Cross-sectional analysis of the 2009 National Emergency Department Sample, an all-payer a…
Promoting Transparency in Pharmaceutical Industry–Sponsored Research
Strong, evidence-based practice requires that objective, unbiased research be available to inform individual clinical decisions, systematic reviews, meta-analyses, and expert guideline recommendations. Industry has used seeding trials, publication planning, messaging, ghostwriting, and selective publication and reporting of trial outcomes to distort the medical literature and undermine clinical trial research by obscuring information relevant to …
The Use and Misuse of Thrombolytic Therapy Within the Veterans Health Administration
BACKGROUND: Within the Veterans Health Administration (VHA), approximately 6000 veterans are hospitalized with acute ischemic stroke annually. We examined the use and misuse of thrombolytic therapy with tissue plasminogen activator (tPA) in a national sample of veterans who were admitted to a VHA Medical Center (VAMC) with acute ischemic stroke. METHODS: Medical record reviews were conducted on 5000 acute stroke patients who were admitted to a VA…
Association of Chronic Diseases and Impairments With Disability in Older Adults
BACKGROUND: Little is known about how the relationship between chronic disease, impairment, and disability has changed over time among older adults. OBJECTIVE: To examine how the associations of chronic disease and impairment with specific disability have changed over time. RESEARCH DESIGN: Repeated cross-sectional analysis, followed by examining the collated sample using time interaction variables, of 3 recent waves of the Health and Retirement …
Use of Preventive Care by Elderly Male Veterans Receiving Care Through the Veterans Health Administration, Medicare Fee-for-Service, and Medicare HMO Plans
Objectives. We compared use of preventive care among veterans receiving care through the Veterans Health Administration (VHA), Medicare fee-for-service (FFS) plans, and Medicare health maintenance organizations (HMOs). Methods. Using both the Costs and Use, and Access to Care files of the Medicare Current Beneficiary Survey (2000–2003), we performed a cross-sectional analysis examining self-reported use of influenza vaccination, pneumococcal vacc…
Promoting Transparency in Pharmaceutical Industry–Sponsored Research
Strong, evidence-based practice requires that objective, unbiased research be available to inform individual clinical decisions, systematic reviews, meta-analyses, and expert guideline recommendations. Industry has used seeding trials, publication planning, messaging, ghostwriting, and selective publication and reporting of trial outcomes to distort the medical literature and undermine clinical trial research by obscuring information relevant to …
The National Health Service in Great Britain
Use of Preventive Care by Elderly Male Veterans Receiving Care Through the Veterans Health Administration, Medicare Fee-for-Service, and Medicare HMO Plans
Objectives. We compared use of preventive care among veterans receiving care through the Veterans Health Administration (VHA), Medicare fee-for-service (FFS) plans, and Medicare health maintenance organizations (HMOs). Methods. Using both the Costs and Use, and Access to Care files of the Medicare Current Beneficiary Survey (2000–2003), we performed a cross-sectional analysis examining self-reported use of influenza vaccination, pneumococcal vacc…
Racial and ethnic differences in personal cervical cancer screening amongst post-graduate physicians
Among a small group of insured, highly-educated physicians who have access to health care, we found racial and ethnic differences in adherence to cervical cancer screening recommendations, suggesting that culture may play a role in cervical cancer screening
Dual Use of Veterans Affairs Services and Use of Recommended Ambulatory Care
BACKGROUND: Use of more than one health care system to obtain care is common among adults receiving care within the Veterans Affairs (VA) medical system. It is not known what effect using care from multiple sources has on the quality of care patients receive. OBJECTIVES: To examine whether use of recommended ambulatory care services differs between exclusive and dual VA users. METHODS: Cross-sectional analysis of the 2004 Behavior Risk Factor Sur…
Electronic Health Record Components and the Quality of Care
BACKGROUND: Electronic health records (EHRs) have been promoted as an important tool to improve quality of care. We examined the association between EHR components, a complete EHR, and the quality of care. METHODS: Using data from the 2005 National Ambulatory Medical Care Survey and the National Hospital Ambulatory Medical Care Survey, we conducted a cross-sectional analysis of all visits with an established primary care provider and examined the…
Use of Administrative Claims Models to Assess 30-Day Mortality Among Veterans Health Administration Hospitals
BACKGROUND: The Centers for Medicare and Medicaid Services (CMS) publicly reports hospital-specific risk-standardized, 30-day, all-cause, mortality rates (RSMRs) for all hospitalizations among fee-for-service Medicare beneficiaries for acute myocardial infarction (AMI), heart failure (HF), and pneumonia at non-Federal hospitals. OBJECTIVE: To examine the performance of the statistical models used by CMS among veterans at least 65 years of age hos…
Promoting Transparency in Pharmaceutical Industry–Sponsored Research
Strong, evidence-based practice requires that objective, unbiased research be available to inform individual clinical decisions, systematic reviews, meta-analyses, and expert guideline recommendations. Industry has used seeding trials, publication planning, messaging, ghostwriting, and selective publication and reporting of trial outcomes to distort the medical literature and undermine clinical trial research by obscuring information relevant to …
The Use and Misuse of Thrombolytic Therapy Within the Veterans Health Administration
BACKGROUND: Within the Veterans Health Administration (VHA), approximately 6000 veterans are hospitalized with acute ischemic stroke annually. We examined the use and misuse of thrombolytic therapy with tissue plasminogen activator (tPA) in a national sample of veterans who were admitted to a VHA Medical Center (VAMC) with acute ischemic stroke. METHODS: Medical record reviews were conducted on 5000 acute stroke patients who were admitted to a VA…
Association of Chronic Diseases and Impairments With Disability in Older Adults
BACKGROUND: Little is known about how the relationship between chronic disease, impairment, and disability has changed over time among older adults. OBJECTIVE: To examine how the associations of chronic disease and impairment with specific disability have changed over time. RESEARCH DESIGN: Repeated cross-sectional analysis, followed by examining the collated sample using time interaction variables, of 3 recent waves of the Health and Retirement …
US Federal Government Efforts to Improve Clinical Trial Transparency with Expanded Trial Registries and Open Data Sharing
In 2014, the Department of Health and Human Services and the National Institutes of Health published proposals to expand clinical trial registration requirements and to promote sharing of clinical research data, but these and other efforts at improving data transparency and access need to be supported by changes in the academic reward structure and significant funding
Variation in US Hospital Emergency Department Admission Rates by Clinical Condition
BACKGROUND: Variation in hospitalization rates have been described for decades, yet little is known about variation in emergency department (ED) admission rates across clinical conditions. We sought to describe variation in ED risk-standardized admission rates (RSAR) and the consistency between condition-specific ED admission rates within hospitals. METHODS: Cross-sectional analysis of the 2009 National Emergency Department Sample, an all-payer a…
Risk-standardized Acute Admission Rates Among Patients With Diabetes and Heart Failure as a Measure of Quality of Accountable Care Organizations
BACKGROUND: Population-based measures of admissions among patients with chronic conditions are important quality indicators of Accountable Care Organizations (ACOs), yet there are challenges in developing measures that enable fair comparisons among providers. METHODS: On the basis of consensus standards for outcome measure development and with expert and stakeholder input on methods decisions, we developed and tested 2 models of risk-standardized…
Hospital Use of Observation Stays
BACKGROUND: The Centers for Medicare and Medicaid Services publicly reports hospital risk-standardized readmission rates (RSRRs) as a measure of quality and performance; mischaracterizations may occur because observation stays are not captured by current measures. OBJECTIVES: To describe variation in hospital use of observation stays, the relationship between hospitals observation stay use and RSRRs. MATERIALS AND METHODS: Cross-sectional analysi…
Factors Associated with Refugee Acute Healthcare Utilization in Southern Connecticut
Hospital Characteristics Associated With Risk-standardized Readmission Rates
BACKGROUND: Safety-net and teaching hospitals are somewhat more likely to be penalized for excess readmissions, but the association of other hospital characteristics with readmission rates is uncertain and may have relevance for hospital-centered interventions. OBJECTIVE: To examine the independent association of 8 hospital characteristics with hospital-wide 30-day risk-standardized readmission rate (RSRR). DESIGN: This is a retrospective cross-s…
Quality of Care in the United States Territories, 1999–2012
BACKGROUND: Millions of Americans live in the US territories, but health outcomes and payments among Medicare beneficiaries in these territories are not well characterized. METHODS: Among Fee-for-Service Medicare beneficiaries aged 65 years and older hospitalized between 1999 and 2012 for acute myocardial infarction (AMI), heart failure (HF), and pneumonia, we compared hospitalization rates, patient outcomes, and inpatient payments in the territo…
Defining Multiple Chronic Conditions for Quality Measurement
BACKGROUND/OBJECTIVE: Patients with multiple chronic conditions (MCCs) are a critical but undefined group for quality measurement. We present a generally applicable systematic approach to defining an MCC cohort of Medicare fee-for-service beneficiaries that we developed for a national quality measure, risk-standardized rates of unplanned admissions for Accountable Care Organizations. RESEARCH DESIGN: To define the MCC cohort we: (1) identified po…
Statewide Inferior Vena Cava Filter Placement, Complications, and Retrievals
BACKGROUND: Public awareness of inferior vena cava (IVC) filter-related controversies has been elevated by the Food and Drug Administration (FDA) safety communication in 2010. OBJECTIVES: To examine population level trends in IVC filter utilization, complications, retrieval rates, and subsequent pulmonary embolism (PE) risk. DESIGN: A retrospective cohort study. SUBJECTS: Patients receiving IVC filters during 2005-2014 in New York State. MEASURES…
For transparency and accountability more is better
Rural Perceptions of Acute Care at Home
PURPOSE: Hospital-level care at home in urban areas delivers low-cost, high-quality care. Few have attempted to deliver home hospital care in a rural environment, where traditional hospitals are often less equipped to deliver high-quality care. Little is known about rural clinicians' and patients' perceptions regarding rural home hospital care and how the urban model might be adapted to fit rural circumstances. METHODS: We conducted semistructure…
Identification of Hospitals That Care for a High Proportion of Patients With Social Risk Factors
In this cross-sectional study, there were inconsistencies in the identification of hospitals caring for disadvantaged populations using different definitions of social risk factors. Without consensus on how to define disadvantaged hospitals, policies to support such hospitals may be applied inconsistently
Reporting of substance use treatment quality in United States adult drug courts
Spending by the Centers for Medicare & Medicaid Services Before and After Confirmation of Benefit for Drugs Granted US Food and Drug Administration Accelerated Approval, 2012 to 2017
The findings of this cross-sectional study indicate that most of the drugs granted FDA accelerated approval for original indications from 2012 to 2017 lacked confirmatory trials evaluating clinical outcomes to support conversion to standard approval. Automatic coverage mandates produced substantial CMS spending for drugs with unproven clinical benefits
On a Writing & Walking Field Trip with Seven High School Boys Exploring Langston Hughes Sites in Washington, D.C
The city teaches us todaywith brick row houses andfront stoops, bicyclists,the squeal of car brakes.Hurried drivers watch uswaiting on a sidewalk,writing on his front steps.Bikes hiss by, their spokessparkle against a grey sky.My students gazeat Langston’s windows,wondering what poem beganhere, what poem ended here,what poem was tossed away.One moment, they are a riotof laughter, shining withsilly, colliding with each other.The next, they searcht…
Extending the US Food and Drug Administration’s Postmarket Authorities
Under current FDA approaches to drug approval, patients, clinicians, and payers may be left with little confidence about a drug's benefit not only when it first enters the market but also for an extended period thereafter. If policy makers continue to favor earlier market access over evidentiary certainty, flexible approvals must be matched by more expansive use of postmarket safeguards, an approach possible within the FDA's existing legal author…
Medicine (26 obras) · Internal Medicine (12 obras) · Health care (11 obras) · Primary Care and Health Outcomes (11 obras) · Emergency Medicine (10 obras) · Business (9 obras) · Emergency Medicine (9 obras) · Family medicine (9 obras) · Internal Medicine (9 obras) · Political science (9 obras)